Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities

Acta Pharmacologica Sinica
Sharad MangalQi Tony Zhou

Abstract

Lung cancer is the second most prevalent and the deadliest among all cancer types. Chemotherapy is recommended for lung cancers to control tumor growth and to prolong patient survival. Systemic chemotherapy typically has very limited efficacy as well as severe systemic adverse effects, which are often attributed to the distribution of anticancer drugs to non-targeted sites. In contrast, inhalation routes permit the delivery of drugs directly to the lungs providing high local concentrations that may enhance the anti-tumor effect while alleviating systemic adverse effects. Preliminary studies in animals and humans have suggested that most inhaled chemotherapies are tolerable with manageable pulmonary adverse effects, including cough and bronchospasm. Promoting the deposition of anticancer drugs in tumorous cells and minimizing access to healthy lung cells can further augment the efficacy and reduce the risk of local toxicities caused by inhaled chemotherapy. Sustained release and tumor localization characteristics make nanoparticle formulations a promising candidate for the inhaled delivery of chemotherapeutic agents against lung cancers. However, the physiology of respiratory tracts and lung clearance mechanisms present key barr...Continue Reading

References

Jun 1, 1976·Environmental Health Perspectives·H C YehO G Raabe
Jul 1, 1992·Environmental Health Perspectives·J D Brain
Oct 1, 1990·Journal of Applied Physiology·E G LangenbackW M Foster
Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E RappA M Arnold
Jan 1, 1987·Cancer Chemotherapy and Pharmacology·D J Kerr, S B Kaye
Apr 1, 1987·Journal of Applied Physiology·W D Bennett, G C Smaldone
Jul 2, 1966·Nature·C N Davies, D C Muir
Apr 1, 1984·Environmental Health Perspectives·B O Stuart
Nov 1, 1980·British Journal of Industrial Medicine·M LippmannR E Albert
May 1, 1981·American Industrial Hygiene Association Journal·W StahlhofenJ Heyder
Jan 1, 1980·Bulletin of Mathematical Biology·H C Yeh, G M Schum
Aug 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J H SchillerD Johnson
Jun 20, 1997·Science·D A EdwardsR Langer
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·P E BurnettD M Sabatini
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·S K HobbsR K Jain
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·C EvoraR Langer
Aug 4, 1998·Journal of Applied Physiology·D A EdwardsR Langer
Apr 22, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M ChacónM R Aberturas
May 26, 1999·Journal of Drug Targeting·L AraujoJ Kreuter
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C Reed
Nov 26, 1999·Pharmaceutical Research·R VanbeverD A Edwards
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Mar 4, 2000·Advanced Drug Delivery Reviews·J Sudimack, R J Lee
Apr 6, 2000·Pharmaceutical Research·L A DellamaryJ G Weers
Jun 6, 2000·Advanced Drug Delivery Reviews·G Cevc, H Richardsen
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H MüllerS Gohla
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S SharmaM G Kris
Apr 20, 2001·Advanced Drug Delivery Reviews·I M Hafez, P R Cullis
Mar 20, 2002·Current Molecular Medicine·A Palecanda, L Kobzik

❮ Previous
Next ❯

Citations

Jun 2, 2017·Acta Pharmacologica Sinica·Yong-Zhuo Huang, Ya-Ping Li
Nov 14, 2018·Expert Opinion on Drug Delivery·Nasser AlhajjPaolo Colombo
Oct 26, 2018·Journal of Aerosol Medicine and Pulmonary Drug Delivery·James VercoGere diZerega
Jul 10, 2019·Expert Opinion on Drug Delivery·Ah Young LeeSanghwa Kim
Dec 6, 2019·International Journal of Molecular Sciences·Jacob W ShrefflerAmanda E Brooks
Oct 12, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Caleb F AndersonHonggang Cui
Sep 11, 2019·Nanotoxicology·Nashwa M OsmanImran Y Saleem
Sep 3, 2020·Nanomaterials·Sarkar Siddique, James C L Chow
Sep 5, 2019·Current Pharmaceutical Design·Sajjad Molavipordanjani, Seyed Jalal Hosseinimehr
Dec 14, 2019·Biomaterials Research·Dhrisya ChenthamaraM Walid Qoronfleh
Jul 21, 2020·Expert Opinion on Drug Delivery·Manish KumarBrahmeshwar Mishra
Mar 17, 2020·Drug Delivery and Translational Research·Arpit BhargavaPradyumna Kumar Mishra
Sep 18, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Hanui LeeDongwon Lee
Feb 6, 2021·Journal of Biomechanics·Yan OstrovskiJosué Sznitman
Oct 24, 2020·American Journal of Respiratory Cell and Molecular Biology·Zicheng DengVladimir V Kalinichenko
Mar 6, 2021·Chemical Society Reviews·Mauro Sousa de AlmeidaBarbara Rothen-Rutishauser
Jan 22, 2019·Journal of Aerosol Science·Sunil Kumar BodaJingwei Xie
Apr 13, 2021·Beilstein Journal of Nanotechnology·Barbora SvitkovaAlena Gabelova
Apr 22, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Moez GhummanJyothi U Menon
May 7, 2021·Journal of Immunotoxicology·Leonor de BragancaJeremy P Derrick
May 25, 2021·Frontiers in Pharmacology·Si-Min QiJiang-Jiang Qin
Jul 24, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Paraskevi Kyriaki MonouDimitrios G Fatouros

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.